Animal & Veterinary

2012 Letters

Company NameSubjectType of ActionDate of ActionIssuing OfficeProduct(s)Addressee LocationFile
Sogeval Laboratories, Inc.CGMP regulation deviations and unapproved new drugsUL3/12/2012Dallas District Officetopical drug productsTXHTML
Merck Animal HealthPromotional ClaimsUL4/9/2012CVMNADA 141-299, Resflor Gold (florfenicol and flunixin meglumine)NJHTML
Clavel CorporationCGMP regulation deviations and unapproved new drugUL9/18/2012Dallas District OfficeBlue Stop-E, topical pain relieverTXHTML
ProCore Laboratories, LLCCGMP regulation deviations and unapproved new drugUL9/25/2012Dallas District OfficeDouxo Chlorhexidine PS Microemulsion Spray, topical antimicrobialTXHTML
Intervet Inc. (d/b/a Merck Animal Health)Promotional ClaimsUL10/16/2012CVMNADA 141-305, Orbax (orbifloxacin) Oral SuspensionNJPDF

Page Last Updated: 11/14/2017
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English